PMID- 34936855 OWN - NLM STAT- MEDLINE DCOM- 20221004 LR - 20221004 IS - 1502-4725 (Electronic) IS - 0803-9488 (Linking) VI - 76 IP - 7 DP - 2022 Oct TI - Longitudinal persistence of negative symptoms in young individuals with first episode schizophrenia: a 24-month multi-modal program follow-up. PG - 530-538 LID - 10.1080/08039488.2021.2015431 [doi] AB - PURPOSE: Persistent Negative Symptoms (PNS) affect real-world functioning already at the onset of schizophrenia. Longitudinal studies on beneficial effects of psychosocial treatments for PNS in First Episode Schizophrenia (FES) are still relatively scarce. The aim of the current study was to evaluate the longitudinal persistence of PNS in young FES individuals treated according to the multimodal "Early Intervention in Psychosis" (EIP) program over a 2-year follow-up period. MATERIALS AND METHODS: 133 FES subjects (aged 12-35 years) were recruited within the Italian EIP program and completed the Positive And Negative Syndrome Scale (PANSS) and the Global Assessment of Functioning (GAF). In accordance with the PNS criteria, we dichotomized FES individuals with and without PNS. In the FES group with PNS, a multiple linear regression analysis was conducted to examine relevant associations between longitudinal PNS levels and the specialized treatment components of our EIP protocol. RESULTS: Twenty (15%) FES participants met the PNS criteria. At baseline, PNS levels had relevant positive correlations with functioning decline and PANSS total score. At the end, the 2-years follow-up period, FES subjects with PNS showed a significant decrease in PNS levels. In our linear regression analysis, this reduction was associated with a higher number of individual psychotherapy and case management sessions delivered during our follow-up (together with a shorter DUP [Duration of Untreated Psychosis]). CONCLUSIONS: PNS are clinically relevant in a minority of FES individuals. Our results suggest that patient-tailored psychosocial interventions can reduce clinical severity of PNS over a 2-year period. FAU - Pelizza, Lorenzo AU - Pelizza L AUID- ORCID: 0000-0003-4746-2061 AD - Department of Mental Health and Pathological Addiction, Azienda USL di Parma, Parma, Italy. FAU - Leuci, Emanuela AU - Leuci E AD - Department of Mental Health and Pathological Addiction, Azienda USL di Parma, Parma, Italy. FAU - Maestri, Davide AU - Maestri D AD - Department of Mental Health and Pathological Addiction, Azienda USL di Parma, Parma, Italy. FAU - Quattrone, Emanuela AU - Quattrone E AD - Department of Mental Health and Pathological Addiction, Azienda USL di Parma, Parma, Italy. FAU - Azzali, Silvia AU - Azzali S AD - Department of Mental Health and Pathological Addiction, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy. FAU - Paulillo, Giuseppina AU - Paulillo G AD - Department of Mental Health and Pathological Addiction, Azienda USL di Parma, Parma, Italy. FAU - Pellegrini, Pietro AU - Pellegrini P AD - Department of Mental Health and Pathological Addiction, Azienda USL di Parma, Parma, Italy. LA - eng PT - Journal Article DEP - 20211222 PL - England TA - Nord J Psychiatry JT - Nordic journal of psychiatry JID - 100927567 SB - IM MH - Follow-Up Studies MH - Humans MH - Longitudinal Studies MH - *Psychotic Disorders/diagnosis MH - *Schizophrenia/diagnosis MH - Schizophrenic Psychology OTO - NOTNLM OT - Persistent negative symptoms OT - early intervention OT - early schizophrenia OT - first episode schizophrenia OT - follow-up OT - treatment response EDAT- 2021/12/23 06:00 MHDA- 2022/10/05 06:00 CRDT- 2021/12/22 20:09 PHST- 2021/12/23 06:00 [pubmed] PHST- 2022/10/05 06:00 [medline] PHST- 2021/12/22 20:09 [entrez] AID - 10.1080/08039488.2021.2015431 [doi] PST - ppublish SO - Nord J Psychiatry. 2022 Oct;76(7):530-538. doi: 10.1080/08039488.2021.2015431. Epub 2021 Dec 22.